Atmeksi Suspension
Product Images NDC 69528-701

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atmeksi (NDC 69528-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rosemont Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atmeksi Bottle (Atmeksi Bottle 150)

This is information about an oral suspension containing 750 mg of methocarbamol per 5 mL. The recommended dosage should be followed as per prescribing information. It should be stored at room temperature and shaken for 30 seconds before administration. The medicine is for prescription use only and should be kept out of children's reach. For more details, visit osemontpharmaceuticals.com.*

FDA Label Image

Formula (Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.